BIOVIRON SARL - France 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2013 0 11.999.975 473.100 1
2011 0 1.426.776 109.413 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
LUNDS UNIVERSITET2
UNIVERSITA DEGLI STUDI DI FERRARA2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
BENGURION UNIVERSITY OF THE NEGEV1
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INSTYTUT BIOLOGII DOSWIADCZALNEJ IM M NENCKIEGO POLSKIEJ AKADEMII NAUK1
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI1
ITAE SUOMEN YLIOPISTO1
LIFE AND BRAIN1
MEDIZINISCHE HOCHSCHULE HANNOVER1
MICROVITAE TECHNOLOGIES SAS1
NSGENE1
STIFTUNG TIERAERZTLICHE HOCHSCHULE HANNOVER1
TOBBB TECHNOLOGIES BV1
UNIVERSITAETSKLINIKUM BONN1
UNIVERSITE D'AIX MARSEILLE1
UNIVERSITY COLLEGE LONDON1

Constancy:

Total number of partners: 20
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 20
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2013-11-01Targets and biomarkers for antiepileptogenesis EPITARGETparticipant11.999.97518
2011-12-01Innovative gene therapies for epilepsy treatment EPIXCHANGEparticipant1.426.7764